Myomo, Inc.
AMEX:MYOMedical - Devices
-$0.13 today
- Market cap
- $50.12M
- Beta
- 1.46
- P/E (TTM)
- -3.6
- EPS (TTM)
- -$0.36
Volume 0.21M
Average 0.62M
MYO Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Myomo, Inc.AMEX: MYO
Total Equity · Q1 FY2026 · quarter ended Mar 2026
Total equity falls 58.5% from a year ago
Total equity stood at $9M at the end of Q1 FY2026, down 58.5% from a year earlier and down 21.1% from the prior quarter. Over 3 fiscal years it compounded at +21.5% a year.
Context
- Total equity amounted to 24.5% of total assets at the end of Q1 FY2026, down 28.6 pp from a year earlier.
- Total equity increased in 2 of the last 3 fiscal years.
What to watch
Whether total equity keeps falling in the next quarterly balance sheet after a -58.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 11.4M USD
- Year-over-year change
- -53.9%
- 4-year CAGR
- -7.2%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.4M | -53.9% |
| FY2024 | 2024-12-31 | 24.71M | +174.9% |
| FY2023 | 2023-12-31 | 8.99M | +41.4% |
| FY2022 | 2022-12-31 | 6.36M | -58.7% |
| FY2021 | 2021-12-31 | 15.41M | — |
Total Equity vs competitors
How MYO compares with its peers on the latest reported figures
- MYO's Mar 2026 total equity of $9M is the 3rd highest of the 4 companies compared; the peer median is $20.11M.
- Its year-over-year change of -58.5% is the 3rd highest of 4, against a peer median of +52.6%.
- Total equity amounts to 24.5% of total assets for MYO, versus a peer median of 59.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $101.93M | +172.9% | +33.6% | 90.1% | |
| Mar 2026 | $20.11M | +52.6% | +11.0% | 59.7% | |
| Mar 2026 | $9M | -58.5% | +21.5% | 24.5% | |
| Mar 2026 | -$5.69M | -230.3% | — | 36.7% | |
| Peer median (excluding MYO) | $20.11M | +52.6% | +22.3% | 59.7% | |
Competitors are the stored peer set for MYO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 15.52M | 5.35M | 6.87M | 24.37M | 14.13M |
| Short-term Investments | 0 | 0 | 1.99M | 492.99K | 4.26M |
| Net Receivables | 1.96M | 1.9M | 2.38M | 3.83M | 4.1M |
| Inventory | 808.31K | 1.4M | 1.8M | 3.17M | 3.12M |
| Other Current Assets | (95.33K) | 573.46K | 598.85K | 933.38K | 1.94M |
| Total Current Assets | 19.09M | 9.22M | 13.65M | 32.79M | 27.56M |
| Property, Plant & Equipment (Net) | 908.2K | 703.03K | 839.35K | 8.91M | 6.68M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 1.59M |
| Long-term Investments | 0 | 132.49K | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 95.33K | 111.03K | 91.24K | 539.41K | 2.81M |
| Total Non-current Assets | 1M | 946.55K | 930.59K | 9.45M | 11.08M |
| Total Assets | 20.1M | 10.16M | 14.58M | 42.24M | 38.64M |
| Account Payables | 723.35K | 569.68K | 1.07M | 1.17M | 1.51M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 39.15K | 48.22K | 96.46K | 318.89K | 813.26K |
| Deferred Revenue | 192.75K | 773.89K | 1.12M | 2.28M | 2.15M |
| Other Current Liabilities | 2.48M | 1.19M | 2.2M | 5.14M | 3.1M |
| Total Current Liabilities | 4.28M | 3.6M | 5.48M | 10.17M | 8.35M |
| Long-term Debt | 0 | 0 | 0 | 0 | 11.22M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 1.25K | 498 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 402.87K | 200.71K | 115.16K | 7.36M | 18.89M |
| Total Liabilities | 4.69M | 3.8M | 5.59M | 17.53M | 27.23M |
| Common Stock | 687 | 775 | 2.72K | 3.44K | 3.85K |
| Retained Earnings | (78.06M) | (88.78M) | (96.93M) | (103.11M) | (118.69M) |
| Accumulated OCI | (60.68K) | 43.23K | 83.67K | (14.41K) | 164.52K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 15.41M | 6.36M | 8.99M | 24.71M | 11.4M |
| Total Debt | 735K | 553.91K | 601.3K | 8.11M | 19.38M |
| Net Debt | (14.79M) | (4.79M) | (6.27M) | (16.27M) | 5.25M |
Myomo, Inc.
AMEX:MYO
Intrinsic Alpha fair value
Locked
Current Price
$1.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.